Visual Universitätsmedizin Mainz

Fachveranstaltungen und Fort- und Weiterbildungen

Fachveranstaltung Translational Oncology Seminar: "Regulation of tumor immunity by macrophage and eosinophils"

Veranstalter: TRON - Translational Oncology Mainz

    The TRON (Translational Oncology at the University Medical Center) kindly invites you to their Seminar in Translational Oncology by Prof. Günter Hämmerling from the Division of Molecular Immunology at the German Cancer Research Center in Heidelberg (DKFZ).

    The presentation is open to everybody.

    The title of his talk will be: Regulation of tumor immunity by macrophage and eosinophils.

    Upon completion of his PhD on the structure of LPS at the Max Planck Institute for Immunobiology in Freiburg, Germany, in 1971, Günter Hämmerling joined the laboratory of Hugh McDevitt at the Stanford University Medical School, USA, for postdoctoral studies devoted to the function of MHC linked "immune response genes", resulting in the description of Ia antigens, known today as MHC class II. In 1974 he joined the laboratory of Klaus Rajewsky at the Institute for Genetics, University of Cologne, Germany, where he introduced monoclonal antibodies for the functional analysis of MHC molecules. Since 1979 Günter Hämmerling has held the position of Chairman of the Division of Molecular Immunology at the German Cancer Research Center Heidelberg, Germany, where the work on MHC molecules was extended to antigen presentation components, peripheral tolerance, and tumor immunology. This work led to the clinically important observation that the degree of T cell infiltration into tumors can be manipulated genetically or by inflammatory mediators, resulting in more efficient elimination of tumors.

    Günter Hämmerling is a member the European Molecular Biology Organization EMBL. He served on various Scientific Advisory Boards including the Helmholtz Center for Infection Research HZI, Braunschweig, Germany, the German Center for Rheumatology Research DRFZ, Berlin, Germany, the Association for Immunotherapy of Cancer CIMT, the World Premier Institutes Japan. He was co-founder and president of the European Network of Immunology Institutes ENII, and president of the German Society of Immunology DGfI. He also serves on a number of editorial boards of scientific journals. To date, he has authored more than 350 publications in leading scientific journals.

    Information about his publications can be found at:


Datum Thursday 7. April 2016
Uhrzeit 17:15 Uhr

University Medical Center, Building 708, Lecture Hall


Prof. Günter Hämmerling, Division of Molecular Immunology at the German Cancer Research Center in Heidelberg (DKFZ)

Fortbildungspunkte 0,1 CP TransMed

Dr. Goran Martić
Project- and Cooperations Management


Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz gGmbH
Freiligrathstr. 12
55131 Mainz
Fon      06131-2161 474
Fax      06131-2161 400

Downloads TRON_Seminar_April_07_2016.pdf